Last 47 quarters of trend data · Healthcare · Medical - Healthcare Plans
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 28.11 | 17.17 | 9.80 | 7502.50 | 33.33 | 20.85 | 19.11 | 21.15 | 22.45 | 28.04 | — | 22.58 | 20.20 | 20.65 | 19.86 | 26.35 | 22.75 | 24.05 | 24.19 | 29.47 | 22.82 |
| — | -17.6% | -48.7% | +35376.2% | +48.4% | -25.6% | — | -6.3% | +11.2% | +35.8% | — | -14.3% | -11.2% | -14.1% | -17.9% | -10.6% | -0.3% | +7.1% | +32.1% | -22.7% | -3.4% | |
| P/S Ratio | 0.75 | 0.84 | 0.55 | 0.66 | 0.70 | 0.64 | 1.10 | 1.16 | 1.35 | 1.20 | 1.14 | 1.30 | 1.28 | 1.22 | 1.21 | 1.52 | 1.48 | 1.52 | 1.52 | 1.63 | 1.29 |
| — | +32.1% | -49.8% | -43.0% | -48.4% | -46.8% | -4.0% | -10.8% | +5.6% | -1.7% | -5.7% | -14.0% | -13.7% | -19.9% | -20.1% | -6.7% | +14.7% | +13.2% | +19.7% | +26.3% | +12.0% | |
| P/B Ratio | 3.33 | 3.55 | 2.34 | 2.95 | 2.98 | 2.71 | 4.57 | 4.57 | 5.21 | 4.76 | 4.71 | 4.98 | 5.02 | 4.90 | 4.92 | 5.81 | 5.77 | 6.01 | 6.27 | 6.27 | 5.00 |
| — | +31.2% | -48.9% | -35.4% | -42.8% | -43.1% | -2.9% | -8.1% | +3.7% | -2.9% | -4.3% | -14.4% | -13.0% | -18.5% | -21.5% | -7.3% | +15.5% | +15.2% | +24.2% | +31.2% | +16.6% | |
| P/FCF | 21.01 | 9.18 | 7.55 | 469.38 | 15.57 | 11.26 | 26.37 | 80.46 | 10.49 | 20.05 | 284.36 | — | 19.46 | 11.07 | 7.16 | — | 6.71 | 19.63 | 25.53 | 47.52 | 13.42 |
| — | -18.5% | -71.4% | +483.4% | +48.4% | -43.8% | -90.7% | — | -46.1% | +81.1% | +3873.2% | — | +189.7% | -43.6% | -72.0% | — | -50.0% | +2.1% | +55.9% | +211.7% | -54.0% | |
| EV / EBITDA | 16.80 | 11.58 | 7.39 | 59.19 | 16.99 | 13.41 | 13.05 | 14.76 | 15.11 | 14.65 | 14.04 | 15.42 | 13.02 | 13.10 | 13.09 | 17.03 | 14.73 | 16.22 | 16.43 | 19.97 | 15.33 |
| — | -13.7% | -43.4% | +300.9% | +12.4% | -8.5% | -7.0% | -4.2% | +16.1% | +11.9% | +7.2% | -9.5% | -11.7% | -19.2% | -20.3% | -14.7% | -3.9% | +6.6% | +28.8% | -6.6% | +0.9% | |
| EV / EBIT | 20.66 | 13.19 | 8.17 | 348.84 | 21.73 | 16.37 | 14.59 | 16.70 | 16.96 | 19.60 | 148.32 | 17.37 | 14.55 | 14.76 | 14.67 | 19.46 | 16.37 | 18.04 | 18.29 | 22.75 | 17.46 |
| — | -19.4% | -44.0% | +1989.3% | +28.1% | -16.5% | -90.2% | -3.9% | +16.5% | +32.8% | +911.4% | -10.7% | -11.1% | -18.2% | -19.8% | -14.5% | -6.3% | +4.9% | +29.0% | -12.0% | -0.4% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 18.5% | 32.7% | 22.7% | 16.3% | 18.2% | 17.9% | 21.7% | 21.1% | 22.8% | 22.3% | 23.1% | 23.3% | 25.3% | 24.6% | 24.7% | 25.2% | 24.7% | 24.5% | 23.9% | 23.8% | 23.8% |
| — | +82.6% | +4.8% | -22.7% | -20.2% | -19.6% | -5.9% | -9.3% | -9.8% | -9.4% | -6.6% | -7.6% | +2.7% | +0.7% | +3.3% | +5.8% | +3.5% | +1.9% | -5.4% | -1.0% | -0.2% | |
| Operating Margin | 4.2% | 7.1% | 8.0% | 0.3% | 3.8% | 4.6% | 8.3% | 7.7% | 8.6% | 8.0% | 7.9% | 8.1% | 9.2% | 8.7% | 8.8% | 8.3% | 9.2% | 8.9% | 8.7% | 7.5% | 7.9% |
| — | +54.6% | -3.3% | -95.6% | -55.9% | -42.1% | +4.7% | -5.3% | -6.4% | -8.1% | -9.6% | -2.2% | +0.1% | -2.3% | +1.4% | +10.8% | +16.8% | +5.9% | -9.7% | +39.9% | +10.6% | |
| Net Margin | 2.7% | 4.9% | 5.6% | 0.0% | 2.1% | 3.1% | 5.7% | 5.5% | 6.0% | 4.3% | -1.4% | 5.8% | 6.3% | 5.9% | 6.1% | 5.8% | 6.5% | 6.3% | 6.3% | 5.5% | 5.6% |
| — | +60.4% | -2.1% | -99.8% | -65.5% | -28.4% | +506.7% | -4.8% | -5.0% | -27.6% | -123.1% | +0.5% | -2.8% | -6.6% | -2.7% | +4.2% | +15.2% | +5.5% | -9.4% | +63.4% | +16.0% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 11.8% | 5.2% | 6.1% | 0.0% | 2.2% | 3.2% | 6.1% | 5.4% | 5.9% | 4.3% | -1.4% | 5.7% | 6.3% | 6.0% | 6.3% | 5.6% | 6.4% | 6.4% | 6.5% | 5.4% | 5.5% |
| — | +60.0% | +0.2% | -99.8% | -62.5% | -24.5% | +520.9% | -5.3% | -5.3% | -28.2% | -122.7% | +0.5% | -2.2% | -6.2% | -2.8% | +4.4% | +16.1% | +7.7% | -5.3% | +71.1% | +20.4% | |
| ROA | 4.0% | 1.8% | 2.0% | 0.0% | 0.8% | 1.1% | 2.1% | 1.9% | 2.1% | 1.5% | -0.5% | 2.0% | 2.1% | 1.9% | 2.1% | 1.9% | 2.2% | 2.2% | 2.3% | 1.9% | 1.9% |
| — | +60.0% | -2.5% | -99.8% | -63.6% | -25.5% | +509.7% | -5.5% | -0.4% | -23.9% | -123.8% | +0.8% | -6.6% | -13.6% | -8.6% | +1.8% | +15.2% | +9.4% | -4.0% | +68.0% | +16.7% | |
| ROIC | 9.2% | 4.0% | 4.3% | 0.2% | 2.1% | 2.5% | 4.4% | 3.8% | 4.4% | 4.1% | 4.2% | 4.4% | 5.5% | 5.1% | 5.1% | 4.8% | 5.6% | 5.2% | 5.2% | 4.1% | 4.2% |
| — | +59.3% | -1.7% | -95.3% | -53.0% | -39.0% | +5.0% | -13.8% | -19.7% | -20.8% | -16.9% | -8.2% | -2.2% | -0.3% | -2.6% | +17.5% | +31.7% | +14.1% | -0.4% | +51.0% | +14.3% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.77 | 0.69 | 0.74 | 0.77 | 0.76 | 0.76 | 0.77 | 0.75 | 0.75 | 0.76 | 0.76 | 0.68 | 0.67 | 0.71 | 0.78 | 0.67 | 0.59 | 0.63 | 0.61 | 0.60 | 0.63 |
| — | -8.4% | -4.3% | +2.8% | +1.4% | -0.1% | +1.7% | +10.0% | +10.8% | +6.3% | -2.5% | +2.2% | +14.9% | +12.4% | +27.3% | +10.9% | -6.7% | -3.7% | -6.7% | -2.4% | +0.5% | |
| Debt / EBITDA | 3.36 | 8.12 | 7.78 | 52.36 | 14.80 | 12.70 | 7.98 | 8.73 | 8.00 | 8.44 | 8.25 | 7.78 | 6.65 | 7.23 | 7.79 | 7.32 | 5.87 | 6.48 | 6.14 | 7.29 | 7.22 |
| — | -36.1% | -2.6% | +500.1% | +85.0% | +50.5% | -3.2% | +12.1% | +20.4% | +16.9% | +5.8% | +6.4% | +13.2% | +11.5% | +27.0% | +0.4% | -18.7% | -9.2% | -0.5% | -28.8% | -11.5% | |
| Current Ratio | 0.79 | 1.24 | 0.80 | 0.79 | 0.82 | 0.85 | 0.85 | 0.83 | 0.91 | 0.88 | 0.85 | 0.79 | 0.80 | 0.80 | 0.81 | 0.77 | 0.82 | 0.77 | 0.78 | 0.79 | 0.77 |
| — | +46.7% | -5.9% | -4.6% | -9.4% | -3.8% | -0.4% | +4.4% | +12.9% | +10.5% | +5.7% | +2.3% | -2.0% | +3.2% | +3.0% | -1.9% | +6.1% | +0.1% | +6.1% | +6.3% | -5.9% | |
| Quick Ratio | 0.79 | 1.24 | 0.80 | 0.79 | 0.82 | 0.85 | 0.85 | 0.83 | 0.91 | 0.88 | 0.85 | 0.79 | 0.80 | 0.80 | 0.81 | 0.77 | 0.82 | 0.77 | 0.78 | 0.79 | 0.77 |
| — | +46.7% | -5.9% | -4.6% | -9.4% | -3.8% | -0.4% | +4.4% | +12.9% | +10.5% | +5.7% | +2.3% | -2.0% | +3.2% | +3.0% | -1.9% | +6.1% | +0.1% | +6.1% | +6.3% | -5.9% | |
| Interest Coverage | 4.67 | 8.24 | 9.49 | 0.26 | 4.22 | 4.97 | 9.12 | 7.77 | 8.09 | 6.75 | 1.00 | 9.26 | 10.22 | 9.73 | 10.72 | 10.19 | 14.46 | 15.27 | 16.05 | 12.86 | 13.54 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Bull/bear thesis, analyst target revisions, and earnings execution.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying UNH stock.
UnitedHealth Group Incorporated's current P/E is 28.1x. The average P/E over the last 4 quarters is 1890.7x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
UnitedHealth Group Incorporated's current operating margin is 4.2%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking UnitedHealth Group Incorporated's business trajectory between earnings reports.